Related Experiment Video
Updated: Sep 18, 2025
05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
3.0K
Pulsta Valve, Unique Self-Expandable Transcatheter Pulmonary Valve
1Department of Pediatrics, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, Korea. ped9526@snu.ac.kr.
Korean Circulation Journal
|June 19, 2025
Summary
The Pulsta valve, a large self-expandable transcatheter pulmonary valve, shows adaptability for diverse right ventricular outflow tract (RVOT) lesions. Its tissue-engineered design and nitinol stent offer durability and safety, with over 750 cases demonstrating its efficacy.
Area of Science:
- Cardiovascular Surgery
- Biomaterials Science
- Medical Devices
Background:
- Transcatheter pulmonary valve replacement is evolving with large, self-expandable options.
- Native right ventricular outflow tract (RVOT) lesions require durable and adaptable valve solutions.
- The Pulsta valve is a novel tissue-engineered, self-expandable transcatheter pulmonary valve.
Purpose of the Study:
- To evaluate the adaptability and initial outcomes of the Pulsta valve in various RVOT anatomies.
- To highlight the design features contributing to the valve's durability and procedural safety.
- To assess the potential of the Pulsta valve as a next-generation solution for RVOT lesions.
Main Methods:
- Worldwide case series analysis of over 750 implantations by February 2025.
- Utilized decellularization and alpha-galactosidase treatment for tissue engineering.
- Employed a knitted woven nitinol wire stent for structural integrity.
- Leveraged a compact tubular design for ease of delivery and trackability.
Main Results:
- Demonstrated adaptability across diverse main and branch pulmonary artery (PA) anatomies, including complex shapes and pre-stented lesions.
- Successfully implanted in extremely large RVOTs and in cases of stenotic RVOT or failed bioprosthetic valves.
- Reported features like recapturability and system retrieval enhance procedural safety.
Conclusions:
- The Pulsta valve exhibits proven adaptability for a wide range of RVOT conditions.
- Its tissue-engineered durability and nitinol stent design mitigate risks associated with dynamic RVOT environments.
- Further research is needed to fully understand long-term outcomes and expand applicability across all RVOT diseases.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
29
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
29
01:16Heart Valves
5.9K
The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
5.9K